MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Bankruptcy Filing, Financial Collapse
Impel Pharmaceuticals Inc. (NASDAQ: IMPL)
Organization & Developments: Impel Pharmaceuticals
Parents
Impel Pharmaceuticals Inc. (NASDAQ: IMPL)
Children
2022: Impel Pharmaceuticals’ Trudhesa is a drug-device combination that delivers medication through the nose to treat migraines.
Offers and develops treatments that pair the Company’s proprietary Precision Olfactory Delivery (POD®) technology with well-established therapeutics.
Trudhesa® (dihydroergotamine mesylate) nasal spray (0.725 mg per spray) is now approved for the acute treatment of migraine with or without aura in adults.
Jumps
Finance & Acquisitions: Impel Pharmaceuticals
Key People: Impel Pharmaceuticals